Cargando…

Local Gene Silencing of Monocyte Chemoattractant Protein-1 Prevents Vulnerable Plaque Disruption in Apolipoprotein E-Knockout Mice

Monocyte chemoattractant protein-1 (MCP-1), a CC chemokine (CCL2), has been demonstrated to play important roles in atherosclerosis and becoming an important therapeutic target for atherosclerosis. The present study was undertaken to test the hypothesis that local RNAi of MCP-1 by site-specific deli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiao Ling, Zhang, Peng Fei, Ding, Shi Fang, Wang, Yan, Zhang, Mei, Zhao, Yu Xia, Ni, Mei, Zhang, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299803/ https://www.ncbi.nlm.nih.gov/pubmed/22428064 http://dx.doi.org/10.1371/journal.pone.0033497

Ejemplares similares

Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels
por: Zhong, Lin, et al.
Publicado: (2008)

Combinatorial interference of toll-like receptor 2 and 4 synergistically stabilizes atherosclerotic plaque in apolipoprotein E-knockout mice
por: Yang, Jian Min, et al.
Publicado: (2011)

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
por: Zheng, Fei, et al.
Publicado: (2014)

Natural Killer T Cells Are Involved in Atherosclerotic Plaque Instability in Apolipoprotein-E Knockout Mice
por: Ohmura, Yoshinori, et al.
Publicado: (2021)

Silencing of NONO inhibits abdominal aortic aneurysm in apolipoprotein E‐knockout mice via collagen deposition and inflammatory inhibition
por: Xu, Xingli, et al.
Publicado: (2019)

The Fat-Fed Apolipoprotein E Knockout Mouse Brachiocephalic Artery in the Study of Atherosclerotic Plaque Rupture
por: Bond, Andrew R., et al.
Publicado: (2011)

Dietary Egg Sphingomyelin Prevents Aortic Root Plaque Accumulation in Apolipoprotein-E Knockout Mice
por: Millar, Courtney L., et al.
Publicado: (2019)

FRI107 Ketogenic Diet Prevents Development Of Atherosclerotic Plaques In Apolipoprotein E Knockout Mice
por: Marzolla, Vincenzo, et al.
Publicado: (2023)

Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
por: Lim, Jun Pei, et al.
Publicado: (2015)

Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E–knockout mice
por: Li, Gang, et al.
Publicado: (2014)

The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders
por: Yong, Cai, et al.
Publicado: (2014)

Atherosclerosis affects calcium signalling in endothelial cells from apolipoprotein E knockout mice before plaque formation
por: Prendergast, Clodagh, et al.
Publicado: (2014)

Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using (111)In-tilmanocept
por: Varasteh, Zohreh, et al.
Publicado: (2017)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

Doxycycline Stabilizes Vulnerable Plaque via Inhibiting Matrix Metalloproteinases and Attenuating Inflammation in Rabbits
por: Dong, Mei, et al.
Publicado: (2012)

Hyperhomocysteinemia-Induced Monocyte Chemoattractant Protein-1 Promoter DNA Methylation by Nuclear Factor-κB/DNA Methyltransferase 1 in Apolipoprotein E–Deficient Mice
por: Wang, Ju, et al.
Publicado: (2013)

Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-κB activation in apolipoprotein-E-deficient mice
por: Zhao, Dong, et al.
Publicado: (2016)

The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis
por: Kadoglou, N.P.E., et al.
Publicado: (2013)

Perforin and Granzyme B Have Separate and Distinct Roles during Atherosclerotic Plaque Development in Apolipoprotein E Knockout Mice
por: Hiebert, Paul R., et al.
Publicado: (2013)

Xyloketal B Attenuates Atherosclerotic Plaque Formation and Endothelial Dysfunction in Apolipoprotein E Deficient Mice
por: Zhao, Li-Yan, et al.
Publicado: (2015)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Dynamic monocyte chemoattractant protein-1 level as predictors of perceived pain during first and second phacoemulsification eye surgeries in patients with bilateral cataract
por: Zhang, Feng, et al.
Publicado: (2021)

Decreased Serum Monocyte Chemoattractant Protein-1 (MCP-1) Expression in Patients with Upper Gastrointestinal Bleeding
por: Xing, Guohui, et al.
Publicado: (2019)

Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice
por: Li, Bo, et al.
Publicado: (2016)

Interleukin-17A influences the vulnerability rather than the size of established atherosclerotic plaques in apolipoprotein E-deficient mice
por: Wang, Bo, et al.
Publicado: (2022)

Disruption of Lipid Raft Function Increases Expression and Secretion of Monocyte Chemoattractant Protein-1 in 3T3-L1 Adipocytes
por: Lu, Juu-Chin, et al.
Publicado: (2016)

Serum Levels of Monocyte Chemoattractant Protein-1 and All-Cause and Cardiovascular Mortality among Patients with Coronary Artery Disease
por: Ding, Ding, et al.
Publicado: (2015)

Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 Levels Unaltered in Symptomatic Atherosclerotic Carotid Plaque Patients from North India
por: Khurana, Dheeraj, et al.
Publicado: (2013)

Correlation analysis of monocyte chemoattractant protein-1 and clinical characteristics and cognitive impairment in type 2 diabetes mellitus comorbid major depressive disorder
por: Cao, Fang, et al.
Publicado: (2023)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

Chemoattractant-induced activation of c-fos gene expression in human monocytes
Publicado: (1987)

Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
por: Mitchell, Ryan M, et al.
Publicado: (2009)

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

Sildenafil restores endothelial function in the apolipoprotein E knockout mouse
por: Balarini, Camille M, et al.
Publicado: (2013)

Age-Related Changes in the Behavior of Apolipoprotein E Knockout Mice
por: Fuentes, Dasha, et al.
Publicado: (2018)

Apolipoprotein E knockout rabbit model of intracranial atherosclerotic disease
por: Zabriskie, Matthew S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eco2m0ag8mdmi26ohnusb6or0p